Further profiles of granisetron (Kytril): effect on quality of life and pharmacoeconomics.
Eisenberg
P D
PD
Marin Oncology Associates, Greenbrae, CA 94904-2007.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D017829:Granisetron / Q000191:economics* / Q000627:therapeutic use*; D017048:Health Care Costs; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000191:economics / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics; D011788:Quality of Life; D014481:United States; D014839:Vomiting / Q000139:chemically induced / Q000191:economics / Q000517:prevention & control
D000970:Antineoplastic Agents; D017829:Granisetron